[1. WARTENBERG KE, MAYER SA. Medical Complications After Subarachnoid Hemorrhage. Neurosurg Clin N Am. 2010; 21(2):325–38.10.1016/j.nec.2009.10.012]Search in Google Scholar
[2. ARONOW WS. Neurogenic stress cardiomyopathy associated with subarachnoid hemorrhage. Future Cardiol. 2015; 11(1):77–87.10.2217/fca.14.73]Search in Google Scholar
[3. HUANG CC, HUANG CH, KUO HY, CHAN CM, CHEN JH, CHEN WL. The 12-lead electrocardiogram in patients with subarachnoid hemorrhage: Early risk prognostication. Am J Emerg Med. 2012; 30(5):732–6.10.1016/j.ajem.2011.05.003]Search in Google Scholar
[4. MANSELLA G, JEGER R, BINGISSER R, NICKEL C. The Neurocardiogenic Spectrum in Subarachnoid Hemorrhage: A Case Report and Review of the Literature. Clin Pract Cases Emerg Med. 2017; 1(1):16–21.10.5811/cpcem.2016.11.32582]Search in Google Scholar
[5. BISO S, WONGRAKPANICH S, AGRAWAL A, YADLAPATI S, KISHLYANSKY M, FIGUEREDO V. A Review of Neurogenic Stunned Myocardium. Cardiovasc Psychiatry Neurol. 2017; 2017.10.1155/2017/5842182]Search in Google Scholar
[6. BRIGNOLE M, MOYA A, DE LANGE FJ, DEHARO JC, ELLIOTT PM, FANCIULLI A, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018; 39(21):1883–948.10.1093/eurheartj/ehy037]Search in Google Scholar
[7. SUWATCHARANGKOON S, MEYERS E, FALO C, SCHMIDT JM, AGARWAL S, CLAASSEN J, et al. Loss of consciousness at onset of subarachnoid hemorrhage as an important marker of early brain injury. JAMA Neurol. 2016; 73(1):28–35.10.1001/jamaneurol.2015.3188]Search in Google Scholar
[8. CREMERS CHP, VAN DER BILT IAC, VAN DER SCHAAF IC, VERGOUWEN MDI, DANKBAAR JW, CRAMER MJ, et al. Relationship Between Cardiac Dysfunction and Cerebral Perfusion in Patients with Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2016; 24(2):202–6.10.1007/s12028-015-0188-8]Search in Google Scholar
[9. KERRO A, WOODS T, CHANG JJ. Neurogenic stunned myocardium in subarachnoid hemorrhage. J Crit Care. 2017; 38:27–34.10.1016/j.jcrc.2016.10.010]Search in Google Scholar
[10. GHADRI JR, WITTSTEIN IS, PRASAD A, SHARKEY S, DOTE K, AKASHI YJ, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J. 2018; 39(22):2032–46.10.1093/eurheartj/ehy076]Search in Google Scholar
[11. KRISHNAMOORTHY V, BURKHARD MACKENSEN G, GIBBONS EF, VAVILALA MS. Cardiac dysfunction after neurologic injury what do we know and where are we going? Chest. 2016; 149(5):1325–31.10.1016/j.chest.2015.12.014]Search in Google Scholar
[12. TAMIS-HOLLAND JE, JNEID H, REYNOLDS HR, AGEWALL S, BRILAKIS ES, BROWN TM, et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019; 139(18):E891–908.10.1161/CIR.0000000000000670]Search in Google Scholar
[13. KENIGSBERG BB, BARNETT CF, MAI JC, CHANG JJ. Neurogenic Stunned Myocardium in Severe Neurological Injury. Curr Neurol Neurosci Rep. 2019; 19(11).10.1007/s11910-019-0999-7]Search in Google Scholar
[14. ANCONA F, BERTOLDI LF, RUGGIERI F, CERRI M, MAGNONI M, BERETTA L, et al. Takotsubo cardiomyopathy and neurogenic stunned myocardium: Similar albeit different. Eur Heart J. 2016; 37(37):2830–2.10.1093/eurheartj/ehw035]Search in Google Scholar
[15. GUGLIN M, NOVOTOROVA I. Neurogenic Stunned Myocardium and Takotsubo Cardiomyopathy Are the Same Syndrome: A Pooled Analysis. Congest Hear Fail. 2011; 17(3):127–32.10.1111/j.1751-7133.2011.00210.x]Search in Google Scholar
[16. WYBRANIEC M, MIZIA-STEC K, KRZYCH Ł. Neurocardiogenic injury in subarachnoid hemorrhage: A wide spectrum of catecholamin-mediated brain-heart interactions. Cardiol J. 2014; 21(3):220–8.10.5603/CJ.a2014.0019]Search in Google Scholar
[17. MEDINA DE CHAZAL H, DEL BUONO MG, KEYSER-MARCUS L, MA L, MOELLER FG, BERROCAL D, et al. Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018; 72(16):1955–71.10.1016/j.jacc.2018.07.072]Search in Google Scholar
[18. BULSARA KR, MCGIRT MJ, LIAO L, VILLAVICENCIO AT, BOREL C, ALEXANDER MJ, et al. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003; 98(3):524–8.10.3171/jns.2003.98.3.0524]Search in Google Scholar
[19. TEMPLIN C, GHADRI JR, DIEKMANN J, NAPP LC, BATAIOSU DR, JAGUSZEWSKI M, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015; 373(10):929–38.10.1056/NEJMoa1406761]Search in Google Scholar
[20. GHADRI JR, CAMMANN VL, JURISIC S, SEIFERT B, NAPP LC, DIEKMANN J, et al. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail. 2017; 19(8):1036–42.10.1002/ejhf.683]Search in Google Scholar
[21. KWOK CS, KONTOPANTELIS E, MYINT PK, ZAMAN A, BERRY C, KEAVNEY B, et al. Stroke following percutaneous coronary intervention: Type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12. Eur Heart J. 2015; 36(25):1618–28.10.1093/eurheartj/ehv113]Search in Google Scholar
[22. POTTEGÅRD A, RODRÍGUEZ LAG, POULSEN FR, HALLAS J, GAIST D. Antithrombotic drugs and subarachnoid haemorrhage risk: A nationwide case-control study in Denmark. Thromb Haemost. 2015; 114(5):1064–75.10.1160/TH15-04-0316]Search in Google Scholar